We have found 46587 results matching your criteria.
Please wait while we search...

General Material Information

Preferred name caffeine
Trivial Name Caffeine
Short Description 3,7-dihydro-1,3,7-trimethyl-1H-purine
Formula C8 H10 N4 O2
CAS Number 58-08-2
Deleted CAS Number 71701-02-5
FEMA Number 2224
Flavis Number 16.016
ECHA Number 200-362-1
FDA UNII 3G6A5W338E
Nikkaji Number J2.330B
Beilstein Number 0017705
MDL MFCD00005758
COE Number 11741
Bio Activity Summary External link
NMR Predictor External link
FDA Patent No longer provide for the use of these seven synthetic flavoring substances
FDA Mainterm 58-08-2 ; CAFFEINE
Synonyms
  • biogenic caffeine-210
  • caffeine anhydrous
  • caffeine anhydrous USP
  • caffeine natural
  • caffeine USP FCC powder anhydrous
  • coffeine
  • 3,7-dihydro-1,3,7-trimethyl-1H-purine
  • guaranine
  • methyl theobromine
  • 7-methyl theophylline
  • 1-methyl-theobromine
  • 1H- purine-2,6-dione, 3,7-dihydro-1,3,7-trimethyl-
  • theine
  • 1,3,7-trimethyl xanthine
  • 1,3,7-trimethyl-1,3,7-trihydropurine-2,6-dione
  • 1,3,7-trimethyl-1H-purine-2,6(3H,7H)-dione
  • 1,3,7-trimethyl-2,3,6,7-tetrahydro-1H-purine-2,6-dione
  • 1,3,7-trimethyl-2,6-dioxo-1,2,3,6-tetrahydropurine
  • 1,3,7-trimethyl-2,6-dioxopurine
  • 1,3,7-trimethyl-3,7-dihydro-1H-purine-2,6-dione
  • 1,3,7-trimethyl-3,7-dihydro-purine-2,6-dione
  • 1,3,7-trimethylpurine-2,6-dione
  • 1,3,7-trimethylpurine-2,6-dione
  • 1H-Purine-2,6-dione, 3,7-dihydro-1,3,7-trimethyl-
  • 3,7-Dihydro-1,3,7-trimethyl-1H-purine-2,6-dione
  • Methyltheobromine
  • No-Doz
  • Thein
  • 1,3,7-Trimethyl-2,6-dioxopurine
  • 1,3,7-Trimethylxanthine
  • Caffein
  • Cafipel
  • Alert-Pep
  • Koffein
  • Cafeina
  • Mateina
  • Refresh'n
  • Stim
  • Tri-Aqua
  • 7-Methyltheophylline
  • Shape Plus
  • Caffedrine
  • Diurex
  • Stay Alert
  • Synalgos
  • Miudol
  • Wigraine
  • Dasin
  • Phensal
  • DHCplus
  • NSC 5036
  • Durvitan
  • Cafalgine
  • Midron extra
  • New Cetamol
  • Asia migrine
  • Palergot-C
  • Vivarin
  • 1,3,7-Trimethyl-7H-purine-2,6-dione
  • 1,3,7-Trimethyl-2,3,6,7-tetrahydro-1H-purine-2,6-dione
  • 1,3,7-Trimethyl-3,7-dihydro-purine-2,6-dione
  • MeSH ID: D002110

US / EU / FDA / JECFA / FEMA / Scholar / Patents

Google Scholar Start search
Google Books Start search
Google Patents Start search
Perfumer & Flavorists Start search
EU Patents Start search
PubMeb Start search
NCBI Start search

Literature & References

1,3,7-trimethylpurine-2,6-dione
NIST Chemistry WebBook:Search Inchi
Canada Domestic Sub. List:58-08-2
Pubchem (cid):2519
Pubchem (sid):134971358
Publications by PubMed
The coffee genome provides insight into the convergent evolution of caffeine biosynthesis.
Design, formulation and evaluation of green tea chewing gum.
The role of dissolved cations in coffee extraction.
Simultaneous determination of caffeine and some selected polyphenols in Wuyi Rock tea by high-performance liquid chromatography.
Cardiovascular and ride time-to-exhaustion effects of an energy drink.
Chemical composition and sensory evaluation of fermented tea with medicinal mushrooms.
Design, formulation and evaluation of caffeine chewing gum.
Determination of the alkylpyrazine composition of coffee using stable isotope dilution-gas chromatography-mass spectrometry (SIDA-GC-MS).
Identification of aroma active compounds of cereal coffee brew and its roasted ingredients.
The effects of six weeks of supplementation with multi-ingredient performance supplements and resistance training on anabolic hormones, body composition, strength, and power in resistance-trained men.
Identification of enterodiol as a masker for caffeine bitterness by using a pharmacophore model based on structural analogues of homoeriodictyol.
Influence of caffeine on the liking of novel-flavored soda in adolescents.
Effect of physicochemical parameters on enzymatic biodecaffeination during tea fermentation.
Enhancement of fermentation process in Pu-erh tea by tea-leaf extract.
[Neurophysiological effect of flavor and caffeine added to toothpaste].
Identification of bisprenylated benzoic acid derivatives from yerba santa (Eriodictyon ssp.) using sensory-guided fractionation.
Characterization of flavor modulating effects in complex mixtures via high temperature liquid chromatography.
Taste disorders and oral evaluation in patients undergoing allogeneic hematopoietic SCT.
Identification and quantification of free radical scavengers in Pu-erh tea by HPLC-DAD-MS coupled online with 2,2'-Azinobis(3-ethylbenzthiazolinesulfonic acid) diammonium salt assay.
Preservation of kombucha tea-effect of temperature on tea components and free radical scavenging properties.
Conditioned flavor avoidance as a measure of withdrawal in rats chronically exposed to a caffeine solution.
Structural analogues of homoeriodictyol as flavor modifiers. Part III: short chain gingerdione derivatives.
Fast and direct screening of solid materials for their potential liberation of hydrophobic organic compounds using hot cell membrane inlet mass spectrometry.
Effect of supercritical carbon dioxide decaffeination on volatile components of green teas.
Caffeine as a flavor additive in soft-drinks.
New bitter-masking compounds: hydroxylated benzoic acid amides of aromatic amines as structural analogues of homoeriodictyol.
Reinforcing and aversive effects of caffeine measured by flavor preference conditioning in caffeine-naive and caffeine-acclimated rats.
Product-oriented flavor research: learnings from the past, visions for the future.
Taste masking analysis in pharmaceutical formulation development using an electronic tongue.
Chlorogenic acids and lactones in regular and water-decaffeinated arabica coffees.
Does dietary learning occur outside awareness?
Phenolic metabolites from honeybush tea (Cyclopia subternata).
Age-associated increases in intensity discrimination for taste.
Researching on new species of "Mate": Ilex brevicuspis: phytochemical and pharmacology study.
Caffeine-reinforced conditioned flavor preferences in rats.
The science and complexity of bitter taste.
Is caffeine a flavoring agent in cola soft drinks?
Genetic engineering of foods to reduce the risk of heart disease and cancer.
Oral caffeine consumption by rats: the role of flavor history, concentration, concurrent food, and an adenosine agonist.
Solventless determination of caffeine in beverages using solid-phase microextraction with fused-silica fibers.
Use of flavor-amplified foods to improve nutritional status in elderly patients.
Aversive conditioning properties of caffeine in rats.
A confirmatory study of the up-and-down method for acute oral toxicity testing.
Caffeine enhancement of saccharin but not cyclamate flavor avoidance.
Use of taste repellants and emetics to prevent accidental poisoning of dogs.
Caffeine: an update.
The biochemistry and technology of tea manufacture.
Evidence for withdrawal from caffeine by rats.
Caffeine: preferential consumption by rats.
Publications by J-Stage
Coffee and Caffeine Improve Insulin Sensitivity and Glucose Tolerance in C57BL/6J Mice Fed a High-Fat Diet

Other Information

(IUPAC):Atomic Weights of the Elements 2011 (pdf)
Videos:The Periodic Table of Videos
tgsc:Atomic Weights use for this web site
(IUPAC):Periodic Table of the Elements
FDA Substances Added to Food (formerly EAFUS):View
CHEBI:View
CHEMBL:View
Golm Metabolome Database:Search
Metabolomics Database:Search
UM BBD:Search
KEGG (GenomeNet):C07481
HMDB (The Human Metabolome Database):HMDB01847
FooDB:FDB002100
Export Tariff Code:2939.30.0000
FDA Listing of Food Additive Status:View
VCF-Online:VCF Volatile Compounds in Food
ChemSpider:View
Wikipedia:View
Formulations/Preparations:
•formulation names: caffedrine, vivarin, quick-pep •grades: technical; usp; fcc •nodoz keep alert tablets contain 100% caffeine in each tablet •vivarin contains 200 mg caffeine alkaloid and 150 mg dextrose in each tablet

PhysChem Properties

Material listed in food chemical codex Yes
Molecular weight 194.19410705566
Melting Point 235 to 237.5°C @ 760 mm Hg
Vapor Pressure 15 mmHg @ 89 °C
Flash Point TCC Value 176.67 °C TCC
logP (o/w) -0.07
Shelf life 24 months (or longer if stored properly.)
Storage notes Store in cool, dry place in tightly sealed containers, protected from heat and light.
Solubility
acetone, 1 gram in 50 ml acetone Yes
alcohol, 1 gram in 22 ml alcohol of 60% Yes
water, 1 gram in 46 ml water Yes
water, 45.5 grams in 100 ml water @ 65C Yes
water, 2.16E+04 mg/L @ 25 °C (exp) Yes

Organoleptic Properties

Odor Type: Odorless
Odor strength none
General comment At 100.00 %. odorless
Mosciano, Gerard P&F 16, No. 4, 45, (1991) No apparent odor
Flavor Type: Astringent
bitter, astringent, metallic
General comment Astringent
Mosciano, Gerard P&F 16, No. 4, 45, (1991) Lingering bitter, astringent with a slight metallic aftertaste

Occurrences

Potential Uses

Applications
Other purposes Skin conditioning
Cosmetic purposes Fragrance, Skin conditioning

Safety Information

Safety information

Preferred SDS: View
European information :
Most important hazard(s):
Xn - Harmful.
R 22 - Harmful if swallowed.
R 36/37/38 - Irritating to eyes, respiratory system, and skin.
S 02 - Keep out of the reach of children.
S 26 - In case of contact with eyes, rinse immediately with plenty of water and seek medical advice.
S 36/37/39 - Wear suitable clothing, gloves and eye/face protection.
Hazards identification
Classification of the substance or mixture
GHS Classification in accordance with 29 CFR 1910 (OSHA HCS)
None found.
GHS Label elements, including precautionary statements
Pictogram
Hazard statement(s)
None found.
Precautionary statement(s)
None found.
Oral/Parenteral Toxicity:
oral-rat LD50 192 mg/kg
KIDNEY, URETER, AND BLADDER: INTERSTITIAL NEPHRITIS BEHAVIORAL: WITHDRAWAL BRAIN AND COVERINGS: OTHER DEGENERATIVE CHANGES
Journal of New Drugs. Vol. 5, Pg. 252, 1965.

intravenous-rat LD50 105 mg/kg
KIDNEY, URETER, AND BLADDER: STRUCTURAL OR FUNCTIONAL CHANGES IN URETER LUNGS, THORAX, OR RESPIRATION: ACUTE PULMONARY EDEMA
Journal of Pharmacology and Experimental Therapeutics. Vol. 82, Pg. 89, 1944.

intraperitoneal-rat LD50 240 mg/kg
Zeitschrift fuer Ernaehrungswissenschaft. Vol. 15, Pg. 64, 1976.

oral-rabbit LD50 224 mg/kg
Zeitschrift fuer Ernaehrungswissenschaft. Vol. 15, Pg. 64, 1976.

intravenous-rabbit LD50 58 mg/kg
Kiso to Rinsho. Clinical Report. Vol. 13, Pg. 791, 1979.

oral-mouse LD50 127 mg/kg
GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA"
Toxicology and Applied Pharmacology. Vol. 44, Pg. 1, 1978.

intravenous-mouse LD50 62 mg/kg
LUNGS, THORAX, OR RESPIRATION: DYSPNEA BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD
Toxicology Letters. Vol. 29, Pg. 25, 1985.

intraperitoneal-mouse LD50 168 mg/kg
KIDNEY, URETER, AND BLADDER: URINE VOLUME INCREASED BEHAVIORAL: AGGRESSION BEHAVIORAL: CHANGES IN MOTOR ACTIVITY (SPECIFIC ASSAY)
Chemical and Pharmaceutical Bulletin. Vol. 22, Pg. 1459, 1974.

oral-hamster LD50 230 mg/kg
GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA"
Toxicology and Applied Pharmacology. Vol. 44, Pg. 1, 1978.

oral-guinea pig LD50 230 mg/kg
"Abdernalden's Handbuch der Biologischen Arbeitsmethoden." Vol. 4, Pg. 1335, 1935.

oral-bird - wild LD50 316 mg/kg
Archives of Environmental Contamination and Toxicology. Vol. 12, Pg. 355, 1983.

intraperitoneal-cat LDLo 180 mg/kg
"Abdernalden's Handbuch der Biologischen Arbeitsmethoden." Vol. 4, Pg. 1335, 1935.

intravenous-cat LDLo 80 mg/kg
"Abdernalden's Handbuch der Biologischen Arbeitsmethoden." Vol. 4, Pg. 1335, 1935.

oral-cat LDLo 100 mg/kg
"Abdernalden's Handbuch der Biologischen Arbeitsmethoden." Vol. 4, Pg. 1335, 1935.

oral-child LDLo 320 mg/kg
BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD LUNGS, THORAX, OR RESPIRATION: CYANOSIS
Forensic Science. Vol. 3, Pg. 275, 1974.

oral-child TDLo 140 mg/kg
BLOOD: HEMORRHAGE BEHAVIORAL: MUSCLE CONTRACTION OR SPASTICITY) CARDIAC: PULSE RATE INCREASE WITHOUT FALL IN BP
Pediatric Emergency Care. Vol. 10, Pg. 349, 1994.

oral-dog LD50 140 mg/kg
Drugs in Japan Vol. 6, Pg. 174, 1982.

intravenous-dog LDLo 4 mg/kg
"Abdernalden's Handbuch der Biologischen Arbeitsmethoden." Vol. 4, Pg. 1335, 1935.

parenteral-frog LDLo 120 mg/kg
BEHAVIORAL: STIFFNESS BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD CARDIAC: OTHER CHANGES
Naunyn-Schmiedeberg's Archiv fuer Experimentelle Pathologie und Pharmakologie. Vol. 166, Pg. 437, 1932.

oral-guinea pig LD50 230 mg/kg
BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION
Toxicology and Applied Pharmacology. Vol. 2, Pg. 23, 1960.

intraperitoneal-guinea pig LDLo 220 mg/kg
"Abdernalden's Handbuch der Biologischen Arbeitsmethoden." Vol. 4, Pg. 1335, 1935.

oral-human LDLo 192 mg/kg
Journal of New Drugs. Vol. 5, Pg. 252, 1965.

intravenous-human TDLo 7 mg/kg
BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD
Acta Pharmacologica et Toxicologica. Vol. 15, Pg. 331, 1959.

oral-man TDLo 13 mg/kg
BEHAVIORAL: TOXIC PSYCHOSIS
American Journal of Psychiatry. Vol. 143, Pg. 1320, 1986.

oral-man TDLo 51 mg/kg
MUSCULOSKELETAL: TUMORS KIDNEY, URETER, AND BLADDER: "CHANGES IN TUBULES (INCLUDING ACUTE RENAL FAILURE, ACUTE TUBULAR NECROSIS)" CARDIAC: CHANGE IN RATE
Annals of Emergency Medicine. Vol. 18, Pg. 94, 1989.

unreported-mouse LD50 251 mg/kg
Nippon Yakurigaku Zasshi. Japanese Journal of Pharmacology. Vol. 53, Pg. 2S, 1957.

oral-rabbit LD50 224 mg/kg
GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA"
Toxicology and Applied Pharmacology. Vol. 44, Pg. 1, 1978.

intramuscular-rabbit LDLo 200 mg/kg
Journal of Pharmacology and Experimental Therapeutics. Vol. 1, Pg. 572, 1910.

intraperitoneal-rabbit LDLo 150 mg/kg
"Abdernalden's Handbuch der Biologischen Arbeitsmethoden." Vol. 4, Pg. 1335, 1935.

Dermal Toxicity:
subcutaneous-rat LD50 170 mg/kg
Journal of Clinical Pharmacology and Journal of New Drugs. Vol. 7, Pg. 131, 1967.

subcutaneous-mouse LD50 242 mg/kg
Arzneimittel-Forschung. Drug Research. Vol. 6, Pg. 601, 1956.

subcutaneous-cat LDLo 150 mg/kg
"Abdernalden's Handbuch der Biologischen Arbeitsmethoden." Vol. 4, Pg. 1335, 1935.

subcutaneous-dog LD50 100 mg/kg
Drugs in Japan Vol. 6, Pg. 174, 1982.

subcutaneous-frog LDLo 120 mg/kg
Acta Pharmacologica et Toxicologica. Vol. 15, Pg. 331, 1959.

subcutaneous-guinea pig LDLo 200 mg/kg
"Abdernalden's Handbuch der Biologischen Arbeitsmethoden." Vol. 4, Pg. 1335, 1935.

subcutaneous-rabbit LDLo 275 mg/kg
Journal of Pharmacology and Experimental Therapeutics. Vol. 1, Pg. 572, 1910.

Inhalation Toxicity:
Not determined

Safety in use information

Category:
cosmetic and flavor agents
Recommendation for caffeine usage levels up to:
not for fragrance use.
Maximised Survey-derived Daily Intakes (MSDI-EU): 380.00 (μg/capita/day)
Structure Class: III
Use levels for FEMA GRAS flavoring substances on which the FEMA Expert Panel based its judgments that the substances are generally recognized as safe (GRAS).
The Expert Panel also publishes separate extensive reviews of scientific information on all FEMA GRAS flavoring substances and can be found at FEMA Flavor Ingredient Library
publication number: 3. Update in publication number(s): 29
Click here to view publication 3
average usual ppmaverage maximum ppm
baked goods: --
beverages(nonalcoholic): 120.00000150.00000
beverages(alcoholic): --
breakfast cereal: --
cheese: --
chewing gum: --
condiments / relishes: --
confectionery froastings: --
egg products: --
fats / oils: --
fish products: --
frozen dairy: --
fruit ices: --
gelatins / puddings: --
granulated sugar: --
gravies: --
hard candy: --
imitation dairy: --
instant coffee / tea: --
jams / jellies: --
meat products: --
milk products: --
nut products: --
other grains: --
poultry: --
processed fruits: --
processed vegetables: --
reconstituted vegetables: --
seasonings / flavors: --
snack foods: --
soft candy: --
soups: --
sugar substitutes: --
sweet sauces: --
Food categories according to Commission Regulation EC No. 1565/2000 (EC, 2000) in FGE.06 (EFSA, 2002a). According to the Industry the "normal" use is defined as the average of reported usages and "maximum use" is defined as the 95th percentile of reported usages (EFSA, 2002i).
Note: mg/kg = 0.001/1000 = 0.000001 = 1/1000000 = ppm.
average usage mg/kgmaximum usage mg/kg
Dairy products, excluding products of category 02.0 (01.0): 20.0000070.00000
Fats and oils, and fat emulsions (type water-in-oil) (02.0): --
Edible ices, including sherbet and sorbet (03.0): 20.0000070.00000
Processed fruit (04.1): --
Processed vegetables (incl. mushrooms & fungi, roots & tubers, pulses and legumes), and nuts & seeds (04.2): --
Confectionery (05.0): 25.00000100.00000
Chewing gum (05.3): --
Cereals and cereal products, incl. flours & starches from roots & tubers, pulses & legumes, excluding bakery (06.0): --
Bakery wares (07.0): --
Meat and meat products, including poultry and game (08.0): --
Fish and fish products, including molluscs, crustaceans and echinoderms (MCE) (09.0): --
Eggs and egg products (10.0): --
Sweeteners, including honey (11.0): --
Salts, spices, soups, sauces, salads, protein products, etc. (12.0): --
Foodstuffs intended for particular nutritional uses (13.0): --
Non-alcoholic ("soft") beverages, excl. dairy products (14.1): 100.00000175.00000
Alcoholic beverages, incl. alcohol-free and low-alcoholic counterparts (14.2): 25.00000100.00000
Ready-to-eat savouries (15.0): --
Composite foods (e.g. casseroles, meat pies, mincemeat) - foods that could not be placed in categories 01.0 - 15.0 (16.0): --

Safety references

European Food Safety Athority(EFSA):Flavor usage levels; Subacute, Subchronic, Chronic and Carcinogenicity Studies; Developmental / Reproductive Toxicity Studies; Genotoxicity Studies...

European Food Safety Authority (EFSA) reference(s):

Flavouring Group Evaluation 29 (FGE29)[1] - Substance from the priority list: Vinylbenzene from chemical group 31 - Scientific Opinion of the Panel on Food Additives, Flavourings, Processing Aids and Materials in Contact with Food (AFC)
View page or View pdf

Flavouring Group Evaluation 49, (FGE.49)[1]: Xanthin alkaloids from the Priority list from chemical group 30
View page or View pdf

Gathering consumption data on specific consumer groups of energy drinks
View page or View pdf

Extensive literature search as preparatory work for the safety assessment for caffeine
View page or View pdf

Outcome of a public consultation on the draft Scientific Opinion of the EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) on the safety of caffeine
View page or View pdf

EFSA explains risk assessment: Caffeine
View page or View pdf

Scientific Opinion on the safety of caffeine
View page or View pdf

Scientific Opinion on Flavouring Group Evaluation 49, Revision 1 (FGE.49Rev1): xanthine alkaloids from the priority list
View page or View pdf

Outcome of the consultation with Member States and EFSA on the basic substance application for approval of caffeine to be used in plant protection as insecticide in cabbage, potatoes and buxus and as molluscicide in all edible and non-edible crops
View page or View pdf

EPI System: View
ClinicalTrials.gov:search
Daily Med:search
NIOSH International Chemical Safety Cards:search
Chemical Carcinogenesis Research Information System:Search
AIDS Citations:Search
Cancer Citations:Search
Toxicology Citations:Search
Carcinogenic Potency Database:Search
EPA GENetic TOXicology:Search
EPA Substance Registry Services (TSCA):58-08-2
EPA ACToR:Toxicology Data
EPA Substance Registry Services (SRS):Registry
Laboratory Chemical Safety Summary :2519
National Institute of Allergy and Infectious Diseases:Data
WISER:UN 1544
WGK Germany:1
1,3,7-trimethylpurine-2,6-dione
Chemidplus:0000058082
EPA/NOAA CAMEO:hazardous materials
RTECS:58-08-2